Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for SEELQ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2024 -0.972M
March 31, 2024 -4.642M
December 31, 2023 -1.911M
September 30, 2023 -5.749M
June 30, 2023 -5.904M
March 31, 2023 -10.35M
December 31, 2022 -13.09M
September 30, 2022 -11.07M
June 30, 2022 -20.40M
March 31, 2022 -17.04M
December 31, 2021 -18.34M
September 30, 2021 -10.51M
June 30, 2021 -8.894M
March 31, 2021 -11.25M
December 31, 2020 -3.329M
September 30, 2020 -4.18M
June 30, 2020 -6.981M
March 31, 2020 -6.423M
December 31, 2019 -5.118M
September 30, 2019 -2.91M
June 30, 2019 -3.337M
March 31, 2019 -7.94M
December 31, 2018 -6.942M
September 30, 2018 -0.544M
June 30, 2018 -0.332M
Date Value
March 31, 2018 -0.308M
December 31, 2017 -2.498M
September 30, 2017 -3.222M
June 30, 2017 -3.659M
March 31, 2017 -1.192M
December 31, 2016 -2.599M
September 30, 2016 -2.309M
June 30, 2016 -3.807M
March 31, 2016 -5.065M
December 31, 2015 -1.31M
September 30, 2015 -6.594M
June 30, 2015 -8.611M
March 31, 2015 -6.127M
December 31, 2014 -9.118M
September 30, 2014 -4.096M
June 30, 2014 -4.625M
March 31, 2014 -0.192M
December 31, 2013 0.95M
September 30, 2013 -4.357M
June 30, 2013 -5.685M
March 31, 2013 -6.011M
December 31, 2012
September 30, 2012 -2.897M
June 30, 2012 -3.590M
March 31, 2012 -5.159M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Filana Therapeutics, Inc. -3.855M
CorMedix, Inc. 86.06M
Eloxx Pharmaceuticals, Inc. -4.789M
Cannabis Global, Inc. -0.112M
Breakthrough Chemistry, Inc. -0.0073M